Nasdaq IMGN biotechnology

Related by string. * NASDAQ. . nasdaq . NASDAQ : Inc. NASDAQ SCOR . NASDAQ OMX Group . Nasdaq Listing Qualifications . Apple Nasdaq AAPL . Nasdaq / : Immunogen NASDAQ IMGN . Immunogen IMGN . ImmunoGen IMGN . Inc. Nasdaq IMGN . Nasdaq IMGN / BIOTECHNOLOGY . BioTechnology . Biotechnology : NYSE Arca Biotechnology . Cougar Biotechnology . Cougar Biotechnology Inc. . Nature Biotechnology * *

Related by context. Frequent words. (Click for all words.) 73 ImmunoGen Inc. 70 Inc. Nasdaq IMGN 67 Masimo NASDAQ MASI 65 NASDAQ SNTA biopharmaceutical 64 therapeutic monoclonal antibodies 64 Connetics Corporation 64 Inc. Nasdaq NEXM 63 liposomal formulation 63 Inc. NASDAQ CRIS 63 proteasome inhibitor 63 immunotherapeutics 62 Inc. NASDAQ CLDA 62 ImmuneRegen BioSciences Inc. 62 Adnexus Therapeutics 62 Novelos Therapeutics Inc. 62 AEG# 62 TLR9 agonist 62 Callisto Pharmaceuticals Inc. 62 Omeros Corporation 62 novel antibody therapeutics 62 Chemokine Therapeutics 62 Amgen discovers develops 62 Pharsight Corporation 62 Nexavar ® 61 NASDAQ OSIR 61 VIA Pharmaceuticals 61 Nasdaq ENZN 61 NASDAQ AEZS 61 anticancer compounds 61 Roche SIX RO 61 Nasdaq VRTX 61 cancer immunotherapies 61 ARCA biopharma Inc. 61 Onalta 61 EPIX Pharmaceuticals Inc. 61 NASDAQ CRXL 61 NovaBay Pharmaceuticals Inc. 61 immunologic diseases 61 Nanobody 61 Idera Pharmaceuticals 61 vascular disrupting agent 61 Archemix Corp. 61 Initiates Phase II 61 FGFR 61 NYSE Amex INO 60 commercializing therapeutic 60 NovaBay Pharmaceuticals 60 anticancer compound 60 targeted anticancer therapeutics 60 GammaCan 60 humanized antibody 60 Amplimexon 60 prophylactic vaccine 60 selective inhibition 60 Nasdaq ATEC 60 Nasdaq MATK 60 KNS # 60 DRRX 60 Neurogen Corporation 60 Carfilzomib 59 organ transplant rejection 59 Aloxi R 59 Amgen discovers develops manufactures 59 Anika Therapeutics 59 bio therapeutics 59 angiogenesis inhibitor 59 oncolytic 59 CD# expressing 59 recombinant vaccines 59 multi kinase inhibitor 59 Nasdaq ASTM 59 nanomedicines 59 Hana Biosciences 59 therapies Biogen Idec 59 commercializes novel 59 Nastech Pharmaceutical Company 59 Dynavax Technologies Corporation 59 Mersana 59 Panzem R 59 Genaera Corporation 59 antisense drug 59 Epratuzumab 59 proteasome inhibitors 59 optical biosensors 59 novel orally administered 59 chemotherapeutic drug 59 Testim R 59 NASDAQ IMCL 59 Nautilus Biotech 59 NASDAQ LGND 59 Urigen Pharmaceuticals Inc. 59 drug conjugate 59 FoldRx 59 Calistoga Pharmaceuticals 59 Regado Biosciences 58 immunological diseases 58 Advancing Drugs 58 Synergy Pharmaceuticals 58 Hybridon 58 Neogen Corporation 58 Emisphere Technologies

Back to home page